Hepatic PPARγ was significantly elevated in patients with NAFLD, and PPARγ deletion in murine liver cells has been demonstrated to prevent liver injury and steatosis [29]. Here, PPARG is linked to metabolic dysfunction-associated steatotic liver disease.